
Sign up to save your podcasts
Or


Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)?
Credit available for this activity expires: 11/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?ecd=bdc_podcast_libsyn_mscpedu
By Medscape Podcasts4
77 ratings
Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)?
Credit available for this activity expires: 11/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?ecd=bdc_podcast_libsyn_mscpedu

141 Listeners

321 Listeners

558 Listeners

501 Listeners

1,311 Listeners

302 Listeners

253 Listeners

883 Listeners

13 Listeners

16 Listeners

290 Listeners

259 Listeners

3,364 Listeners

197 Listeners

91 Listeners

517 Listeners

60 Listeners

28 Listeners

255 Listeners